Persevere Therapeutics
PrivateLast Round
Seed
Mar 4, 2026
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Persevere Therapeutics is an oncology biotechnology company that develops misetionamide, a novel antineoplastic therapeutic for patients with difficult-to-treat cancers.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Persevere Therapeutics Comparables
Compare Persevere Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Vortex Therapeutics, Inc. | 82% | |
| Peptomyc | 74% | |
| Jazz Pharmaceuticals | 59% |
Persevere Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Mar 4, 2026 |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 4, 2026
$1.6M raised in Seed round.
Recent news
Latest coverage and updates
- hiresSep 4, 2026
Persevere Therapeutics, Inc. hires James Barlow as board.
- hiresAug 31, 2026
Persevere Therapeutics, Inc. hired Jim as Board of Directors on Aug 31st '26.
- recognized_asAug 31, 2026
Persevere Therapeutics, Inc. recognized as 2026 CPRIT Finalist.
Persevere Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Persevere Therapeutics's valuation, stock price, and market status.
Is Persevere Therapeutics a public or private company?
Persevere Therapeutics is a private company.
What is the current stock price of Persevere Therapeutics?
Persevere Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is Persevere Therapeutics worth (valuation)?
Valuation information for Persevere Therapeutics is not publicly available.
Can I buy Persevere Therapeutics stock?
Persevere Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Persevere Therapeutics's last funding round?
Persevere Therapeutics's most recent funding round was Seed on March 4, 2026.
Who are the main investors in Persevere Therapeutics?
Investor information for Persevere Therapeutics is not publicly disclosed.
Will Persevere Therapeutics IPO soon?
No public IPO plans have been announced for Persevere Therapeutics.
How can I track Persevere Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Persevere Therapeutics's secondary market activity and sign up for updates.